12,7500 zł
-1,92% -0,2500 zł
SOPHARMA AD (SPH)

Komunikaty spółki - SOPHARMA

Notification from Ognian Donev in accordance with Regulation 596/2014
Consolidated financial report according to IFRS as at 31 March 2024
Invitation and Materials for Annual General Meeting of Shareholders of Sopharma AD
Sales revenues for April 2024
Individual financial report according to IFRS as at 31 March 2024
Publication of Annual consolidated audited financial report of "Sopharma" AD for 2023 in ESF format
Sales revenues of Sopharma AD for March 2024
Presentation of the Annual Audited Individual Financial Statements of “Sopharma” AD as at 31 December 2022
Sales revenues for February 2024
Incoming transfer from capital increase subject to exercise of warrants from issue BG9200001212
Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 08 March 2024 on the acquisition of shares from a capital increase
Consolidated financial report as of 31 December 2023
Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212
Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the acquisition of shares from a temporary issue/exercise of warrants
Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the exercise of warrants in a capital increase under the condition
Przejdź do strony za 5 Przejdź do strony »

Czy wiesz, że korzystasz z adblocka?
Reklamy nie są takie złe

To dzięki nim możemy udostępniać
Ci nasze treści.